Showing results (1-10 of 491) with videos related to
Sort By:
Pageof 50
Movement Disorders : Official Journal of the Movement Disorder Society|April 11, 2001
Long-duration effect and the postsynaptic compartment: study using a dopamine agonist with a short half-lifeF Stocchi, L Vacca, A Berardelli, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 28, 2003
Combination of two different dopamine agonists in the management of Parkinson's diseaseF Stocchi, A Berardelli, L Vacca, et al.Clinical Neuropharmacology|June 1, 1997
Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's diseaseS Ruggieri, M F De Pandis, A Bonamartini, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 7, 2001
Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term resultsF Stocchi, L Vacca, M F De Pandis, et al.European Neurology|January 1, 1996
Motor fluctuations in levodopa treatment: clinical pharmacologyF Stocchi, A Bonamartini, L Vacca, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 14, 2000
Anorectal function in multiple system atrophy and Parkinson's diseaseF Stocchi, D Badiali, L Vacca, et al.Journal of Neurology|June 9, 1998
Sleep disorders in Parkinson's diseaseF Stocchi, L Barbato, G Nordera, et al.Journal of Neurology|May 1, 1996
Fluctuating parkinsonism: a pilot study of single afternoon dose of levodopa methyl esterF Stocchi, L Barbato, L Bramante, et al.Muscle & Nerve|May 19, 1998
Reciprocal inhibition in forearm muscles in patients with essential tremorB Mercuri, A Berardelli, N Modugno, et al.Neurology|October 13, 2006
Symptom relief in Parkinson disease by safinamide: Biochemical and clinical evidence of efficacy beyond MAO-B inhibitionF Stocchi, L Vacca, P Grassini, et al.Pageof 50